中国肺癌杂志Issue(10)：547-552,6.DOI:10.3779/j.issn.1009-3419.2013.10.09
TUBB3/STMN1基因表达与非小细胞肺癌EGFR通路的相关性
Correlation between Expression of TUBB3/STMN1 and EGFR Signaling Pathway in Non-small Cell Lung Cancer
摘要
Abstract
Background and objective It has been proven that biomarkers play a key role in the individualized treatment of lung cancer. Correlations between expressions of TUBB3/STMN1 and gene mutations of epidermal growth fac-tor receptor (EGFR), Kirsten rat sarcoma viral oncogene homolog (KARS), v-raf murine sarcoma viral oncogene homolog B (BARF), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) in non-small cell lung cancer (NSCLC) would be investigated and this may provide essential signiifcance on prognosis and predictions of drug effciency. Methods hTis study total enrolled 46 NSCLC patients. Tumor specimens were resected. hTe gene expressions of TUBB3, STMN1 were analyzed using branched DNA-liquidchip, and EGFR, KARS, BARF, PI3K gene mutations were detected by xTAG-liquidchip. Correlations between gene expressions and gene mutations were further analyzed by Spearman. Results Co-expressions between TUBB3 and STMN1 are strongly demonstrated, and high expression of TUBB3 always exists as well as high expression of STMN1 (P=0.006). Mean-while mutation of EGFR E21 is negatively correlated with TUBB3, and wild type of EGFR E21 always exists toghther with high expression of TUBB3 (P=0.004,6), whereas mutation of KARS E2 is positively associated with expression level of STMN1 (P=0.038,6). Conclusion Antimicrotubule drug resistance factors of TUBB3 and STMN1 may be related with mutations of EGFR signal pathway, suggesting that EGFR mutation and KARS mutation may be important factors in regulation of TUBB3/STMN1 expression, which provided basic references for chemotherapeutic resistance.关键词
肺肿瘤/TUBB3表达/STMN1表达/EGFR通路Key words
Lung neoplasms/TUBB3/STMN1/EGFR pathway引用本文复制引用
王波,王彬,张连斌,初向阳,余刚..TUBB3/STMN1基因表达与非小细胞肺癌EGFR通路的相关性[J].中国肺癌杂志,2013,(10):547-552,6.基金项目
本研究受解放军总医院临床科研扶持基金（No.2012FC-TSYS-4015）资助 （）
